Device
lotrafilcon A
lotrafilcon A is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Phase Distribution
Ph phase_1
1
25%
Ph not_applicable
3
75%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (25.0%)
N/A3 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
Mucin Balls and Corneal Inflammation Events
NCT01437319
completednot_applicable
Daytime Corneal Swelling During Wear of Narafilcon B Lenses
NCT01444287
completednot_applicable
Evaluation of Daytime Corneal Swelling During Wear of Galyfilcon A Lenses
NCT01482819
completednot_applicable
Clinical Trial of Several Contact Lenses in Extended Wear
NCT00762788
Clinical Trials (4)
Showing 4 of 4 trials
NCT01437319Phase 1
Mucin Balls and Corneal Inflammation Events
NCT01444287Not Applicable
Daytime Corneal Swelling During Wear of Narafilcon B Lenses
NCT01482819Not Applicable
Evaluation of Daytime Corneal Swelling During Wear of Galyfilcon A Lenses
NCT00762788Not Applicable
Clinical Trial of Several Contact Lenses in Extended Wear
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4